Effects of Time From Diagnosis to Treatment and Baseline Vision on Retinal Vein Occlusion Outcomes in Aflibercept 2 mg Phase 3 Trials
{{output}}
Objective: To examine impacts of time since diagnosis of macular edema following central or branch retinal vein occlusion (MEfCRVO or MEfBRVO) to first intravitreal aflibercept 2 mg injection (IAI) and baseline best-corrected vis... ...
